Sotrovimab 500mg/8ml solution for infusion vials

SNOMED code
40227411000001101
Active compound
Sotrovimab
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Non-availability
Actual Products not Available
Non-availability date
Dose form
Discrete
Dose size and units
8 ml, vial
Ingredients
Sotrovimab — 62.5 mg / 1 ml based on ingredient substance
Form & Route
solutioninfusion.intravenous
Solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Xevudy 500mg/8ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd)

Xevudy 500mg/8ml concentrate for solution for infusion vials

SNOMED code
40219311000001106
Supplier
GlaxoSmithKline UK Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
Not available
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Xevudy 500mg/8ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial
40219411000001104   ref. pack
Discontinued


Legal category: POM
5054290001242
05054290001242
5054290001839
NHS Indicative Price
£2,209
• Hospital
  • • Prescription Charges
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd)

Sotrovimab 500mg/8ml solution for infusion vials

SNOMED code
40383311000001100
Supplier
GlaxoSmithKline UK Ltd
Licensed as
None
Availability restrictions
Not available
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial
40383411000001107   ref. pack
Discontinued


Legal category: POM
No Price Available
• Hospital
  • • Prescription Charges

Reference packs

Sotrovimab 500mg/8ml solution for infusion vials 1 vial
SNOMED code
40219011000001108
Quantity and unit
1 vial
Packs